Home LiteratureArticle Details
PMID: 10453421 Published · ppublish English Consensus Development Conference Journal Article Research Support, Non-U.S. Gov't Review

Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

International journal of pancreatology : official journal of the International Association of Pancreatology ·Vol. 25 ·No. 3 ·1999-06-00 ·Pages 195-210

Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I

Abstract

The diagnosis, early assessment, and management of severe acute pancreatitis remain difficult clinical problems. This article presents the consensus obtained at a meeting convened to consider the evidence in these areas. The aim of the article is to provide outcome statements to guide clinical practice, with an assessment of the supporting evidence for each statement. Working groups considered the published evidence in the areas of diagnosis, assessment of severity, nonoperative treatment, and surgical treatment of severe acute pancreatitis. Outcome statements were defined to summarize the conclusions on each point considered. The findings were discussed and agreed on by all participants. A careful assessment was made of the strength of the available evidence (proven, probable, possible, unproven, or inappropriate). There is reliable evidence to support much current practice. Clear guidance can be given in most areas examined, and several areas were identified where further investigation would be helpful. Diagnosis using plasma concentrations of pancreatic enzymes is reliable. Rapid advances are taking place in the assessment of severity. Several new therapeutic strategies show real promise for the reduction of morbidity and mortality rates. Surgical debridement is required for infected pancreatic necrosis, but is less often necessary for sterile necrosis.

MeSH Terms
Acute Disease Anti-Bacterial Agents/therapeutic use Biomarkers/blood Disease Management Enteral Nutrition Humans Necrosis Pancreatitis/blood,diagnosis,prevention & control,therapy Platelet Activating Factor/antagonists & inhibitors Predictive Value of Tests Prognosis Protease Inhibitors/therapeutic use Risk Assessment Severity of Illness Index Sphincterotomy, Endoscopic Tomography, X-Ray Computed Treatment Outcome
Chemicals
Anti-Bacterial Agents Biomarkers Platelet Activating Factor Protease Inhibitors
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Dervenis C
Konstantopoulion, Agia Olga Hospital, Athens, Greece. [email protected]
Johnson C D
Bassi C
Bradley E
Imrie C W
McMahon M J
Modlin I
References (98)
98 references, click to expand
  1. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems.
    Br J Surg. 1990 Nov;77(11):1260-4 PMID: 2253005
  2. Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double-blind multicenter study.
    Int J Pancreatol. 1993 Oct;14(2):117-24 PMID: 7506742
  3. APACHE-II score for assessment and monitoring of acute pancreatitis.
    Lancet. 1989 Jul 22;2(8656):201-5 PMID: 2568529
  4. Necrosectomy and postoperative local lavage in necrotizing pancreatitis.
    Br J Surg. 1988 Mar;75(3):207-12 PMID: 3349326
  5. A fifteen year experience with open drainage for infected pancreatic necrosis.
    Surg Gynecol Obstet. 1993 Sep;177(3):215-22 PMID: 8356492
  6. Activation peptide of carboxypeptidase B in serum and urine in acute pancreatitis.
    Gut. 1998 Jan;42(1):97-102 PMID: 9505893
  7. Prognostic factors in sterile pancreatic necrosis.
    Gastroenterology. 1992 Nov;103(5):1636-40 PMID: 1426885
  8. Antibiotic prophylaxis in the initial management of severe acute pancreatitis.
    Br J Surg. 1998 May;85(5):582-7 PMID: 9635800
  9. The timing of biliary surgery in acute pancreatitis.
    Ann Surg. 1979 May;189(5):654-63 PMID: 443917
  10. Acute necrotizing pancreatitis: a multicenter study.
    Hepatogastroenterology. 1994 Apr;41(2):185-9 PMID: 8056412
  11. A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis.
    Am J Surg. 1991 Jan;161(1):19-24; discussion 24-5 PMID: 1987854
  12. Indications for surgical treatment of acute pancreatitis.
    Hepatogastroenterology. 1993 Dec;40(6):556-62 PMID: 8119640
  13. Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis: a prospective study.
    Br J Surg. 1991 Dec;78(12):1452-6 PMID: 1773324
  14. Interleukin-8 and neutrophil activation in acute pancreatitis.
    Eur J Clin Invest. 1992 Mar;22(3):200-3 PMID: 1582445
  15. Serum interleukin-10 in human acute pancreatitis.
    Dig Dis Sci. 1997 Jul;42(7):1469-72 PMID: 9246048
  16. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicentre study.
    Br J Surg. 1991 Oct;78(10):1230-4 PMID: 1958993
  17. Role of ultrasonographically guided fine-needle aspiration cytology in the diagnosis of infected pancreatic necrosis.
    Br J Surg. 1998 Feb;85(2):179-84 PMID: 9501810
  18. Antibiotic prophylaxis in severe acute pancreatitis.
    Br J Surg. 1996 Jul;83(7):883-4 PMID: 8813769
  19. Dynamic contrast enhanced computed tomography: a precise technique for identifying and localising pancreatic necrosis.
    BMJ. 1990 Jun 2;300(6737):1425-8 PMID: 2379000
  20. Role of endoscopy in gallstone pancreatitis.
    Am J Surg. 1993 Apr;165(4):519-21 PMID: 8480894
  21. Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases.
    Dig Dis Sci. 1985 Oct;30(10):1005-18 PMID: 3896700
  22. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones.
    Lancet. 1988 Oct 29;2(8618):979-83 PMID: 2902491
  23. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis.
    Br J Surg. 1978 May;65(5):337-41 PMID: 348250
  24. Surgical management of acute pancreatitis.
    Br J Surg. 1990 Jan;77(1):5-12 PMID: 2405934
  25. Infected pancreatic necrosis.
    Int J Pancreatol. 1994 Aug;16(1):1-10 PMID: 7806908
  26. Role of phospholipase A2 in human acute pancreatitis.
    Gastroenterology. 1989 Dec;97(6):1521-6 PMID: 2684722
  27. Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis.
    Br J Surg. 1997 Sep;84(9):1239-43 PMID: 9313702
  28. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem.
    Surg Gynecol Obstet. 1993 May;176(5):480-3 PMID: 8480272
  29. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial.
    Br J Surg. 1997 Dec;84(12):1665-9 PMID: 9448611
  30. Surgical strategies in the treatment of pancreatic necrosis and infection.
    Br J Surg. 1991 Feb;78(2):133-7 PMID: 2015459
  31. A compaative study of methods for the prediction of severity of attacks of acute pancreatitis.
    Br J Surg. 1980 Jan;67(1):22-5 PMID: 7357236
  32. Diagnostic value of serum elastase 1 in pancreatic disease.
    Br J Surg. 1987 Jan;74(1):44-7 PMID: 2435358
  33. The radiologic assessment of acute pancreatitis and its complications.
    Pancreas. 1991;6 Suppl 1:S13-22 PMID: 1788247
  34. Acute pancreatitis: value of CT in establishing prognosis.
    Radiology. 1990 Feb;174(2):331-6 PMID: 2296641
  35. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis.
    Ann Surg. 1995 Jul;222(1):57-65 PMID: 7618970
  36. The surgical management of pancreatic abscess.
    Ann R Coll Surg Engl. 1987 Sep;69(5):249-50 PMID: 3674691
  37. Continuous regional arterial infusion of protease inhibitor and antibiotics in acute necrotizing pancreatitis.
    Am J Surg. 1996 Apr;171(4):394-8 PMID: 8604829
  38. Prospective comparison of C-reactive protein level, Ranson score and contrast-enhanced computed tomography in the prediction of septic complications of acute pancreatitis.
    Br J Surg. 1993 Jun;80(6):755-7 PMID: 8330167
  39. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis.
    Gut. 1992 Aug;33(8):1126-8 PMID: 1398241
  40. Prediction of pancreatic necrosis by dynamic pancreatography.
    Ann Surg. 1989 Oct;210(4):495-503; discussion 503-4 PMID: 2802834
  41. High volume lesser sac lavage in acute necrotizing pancreatitis.
    Br J Surg. 1989 Apr;76(4):370-3 PMID: 2655822
  42. Undetected fatal acute pancreatitis: why is the disease so frequently overlooked?
    Am J Gastroenterol. 1991 Mar;86(3):322-6 PMID: 1705388
  43. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis.
    Pancreas. 1991 May;6(3):253-9 PMID: 1713669
  44. Early diagnosis of pancreatic infection by computed tomography-guided aspiration.
    Gastroenterology. 1987 Dec;93(6):1315-20 PMID: 3678750
  45. Improved survival in acute necrotizing pancreatitis despite limiting the indications for surgical debridement.
    Eur J Surg. 1995 Mar;161(3):187-92 PMID: 7599297
  46. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis.
    N Engl J Med. 1997 Jan 23;336(4):237-42 PMID: 8995085
  47. Serum tumour necrosis factor compared with C-reactive protein in the early assessment of severity of acute pancreatitis.
    Br J Surg. 1995 Feb;82(2):271-3 PMID: 7749709
  48. Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease.
    Dig Dis Sci. 1989 Jan;34(1):39-45 PMID: 2463138
  49. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis.
    Gut. 1993 Jan;34(1):41-5 PMID: 7679365
  50. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein.
    Dig Dis Sci. 1995 Nov;40(11):2341-8 PMID: 7587812
  51. Early antibiotic treatment in acute necrotising pancreatitis.
    Lancet. 1995 Sep 9;346(8976):663-7 PMID: 7658819
  52. Early assessment of severity of acute pancreatitis using peritoneal lavage.
    Br Med J. 1977 Nov 26;2(6099):1377-9 PMID: 589222
  53. Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis.
    Pancreas. 1996 Aug;13(2):198-201 PMID: 8829189
  54. Pseudocyst drainage predisposes to infection when pancreatic necrosis is unrecognized.
    Am J Gastroenterol. 1994 Oct;89(10):1781-4 PMID: 7942666
  55. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A.
    Gut. 1992 Sep;33(9):1264-7 PMID: 1427382
  56. Nonsurgical treatment of acute necrotizing pancreatitis.
    Pancreas. 1996 Mar;12(2):142-8 PMID: 8720660
  57. Factors influencing morbidity and mortality in acute pancreatitis; an analysis of 279 cases.
    Gut. 1995 Jul;37(1):121-6 PMID: 7672660
  58. Surgical strategy and management of infected pancreatic necrosis.
    Br J Surg. 1996 Jul;83(7):930-3 PMID: 8813777
  59. Clinical value of pancreatitis-associated protein in acute pancreatitis.
    Am J Gastroenterol. 1997 Oct;92(10):1887-90 PMID: 9382059
  60. Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis.
    Pancreas. 1990 Sep;5(5):626-9 PMID: 2235973
  61. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.
    Int J Pancreatol. 1997 Apr;21(2):105-10 PMID: 9209951
  62. Obesity: an important prognostic factor in acute pancreatitis.
    Br J Surg. 1993 Apr;80(4):484-6 PMID: 8495317
  63. The role of phospholipase A in acute pancreatitis.
    Scand J Gastroenterol. 1980;15(6):641-50 PMID: 7010521
  64. Surgical treatment of acute necrotizing pancreatitis.
    Br J Surg. 1988 Nov;75(11):1119-23 PMID: 3208048
  65. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis.
    Lancet. 1990 Jan 6;335(8680):4-8 PMID: 1967341
  66. Prediction of severity in acute pancreatitis: prospective comparison of three prognostic indices.
    Lancet. 1985 Aug 24;2(8452):403-7 PMID: 2863441
  67. Early treatment of acute biliary pancreatitis by endoscopic papillotomy.
    N Engl J Med. 1993 Jan 28;328(4):228-32 PMID: 8418402
  68. Biliary surgery in the same admission for gallstone-associated acute pancreatitis.
    Br J Surg. 1981 Nov;68(11):758-61 PMID: 6794703
  69. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis.
    Gut. 1998 Mar;42(3):431-5 PMID: 9577354
  70. CT diagnosis and staging of acute pancreatitis.
    Radiol Clin North Am. 1989 Jan;27(1):19-37 PMID: 2642273
  71. A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis.
    Int J Pancreatol. 1997 Feb;21(1):13-9 PMID: 9127169
  72. Is an early ultrasound scan of value in acute pancreatitis?
    Br J Surg. 1982 Jul;69(7):369-72 PMID: 7104603
  73. Deaths from acute pancreatitis: why do we miss the diagnosis so frequently?
    Int J Pancreatol. 1988 May;3(4):273-81 PMID: 2455008
  74. Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis.
    Gastroenterology. 1991 Sep;101(3):782-5 PMID: 1907253
  75. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992.
    Arch Surg. 1993 May;128(5):586-90 PMID: 8489394
  76. [Antibiotic use in necrotizing pancreatitis. Results of a controlled study].
    Dtsch Med Wochenschr. 1997 Mar 21;122(12):356-61 PMID: 9118789
  77. Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis.
    Br J Surg. 1995 Oct;82(10):1414-20 PMID: 7489182
  78. Early assessment of severity in acute pancreatitis.
    Gut. 1984 Dec;25(12):1331-9 PMID: 6392034
  79. Risk of death from acute pancreatitis. Role of early, simple "routine" data.
    Int J Pancreatol. 1996 Feb;19(1):15-24 PMID: 8656023
  80. Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis.
    Scand J Gastroenterol. 1996 Aug;31(8):818-24 PMID: 8858754
  81. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis.
    Br J Surg. 1996 Mar;83(3):349-53 PMID: 8665189
  82. Complications of acute pancreatitis and their management.
    Curr Opin Gen Surg. 1993;:282-6 PMID: 7583992
  83. Diagnostic accuracy of pancreatic enzymes evaluated by use of multivariate data analysis.
    Clin Chem. 1993 Sep;39(9):1960-5 PMID: 7690690
  84. CT-guided aspiration of suspected pancreatic infection: bacteriology and clinical outcome.
    Int J Pancreatol. 1995 Dec;18(3):265-70 PMID: 8708399
  85. Serum phospholipase A2 activity in acute pancreatitis: an early guide to severity.
    Br J Surg. 1989 Jul;76(7):731-2 PMID: 2765813
  86. Early localization of necrosis by contrast-enhanced computed tomography can predict outcome in severe acute pancreatitis.
    Br J Surg. 1996 Jul;83(7):924-9 PMID: 8813776
  87. Obesity as a predictor of severity in acute pancreatitis.
    Int J Pancreatol. 1991 Nov-Dec;10(3-4):247-52 PMID: 1787336
  88. Prognostic factors in acute pancreatitis.
    Gut. 1984 Dec;25(12):1340-6 PMID: 6510766
  89. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group.
    Gastroenterology. 1993 Apr;104(4):1165-70 PMID: 8462805
  90. The diagnosis of acute pancreatitis: enhanced sensitivity from an ELISA assay of lipase.
    Biomed Pharmacother. 1983;37(8):395-8 PMID: 6199049
  91. The incidence and prognosis of body wall ecchymosis in acute pancreatitis.
    Surg Gynecol Obstet. 1984 Oct;159(4):343-7 PMID: 6237447
  92. Timing of intervention in acute pancreatitis.
    Postgrad Med J. 1993 Jul;69(813):509-15 PMID: 8415340
  93. Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis.
    Dig Dis Sci. 1995 Apr;40(4):734-8 PMID: 7720462
  94. Contrast-enhanced computed tomography and microangiography of the pancreas in acute human hemorrhagic/necrotizing pancreatitis.
    Pancreas. 1988;3(1):53-60 PMID: 3362843
  95. Prognostic signs and the role of operative management in acute pancreatitis.
    Surg Gynecol Obstet. 1974 Jul;139(1):69-81 PMID: 4834279
  96. Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin.
    Dig Dis Sci. 1990 Jan;35(1):97-105 PMID: 1688526
  97. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
    N Engl J Med. 1996 Sep 26;335(13):919-23 PMID: 8786777
  98. Evaluation of pancreatic amylase immunoassay in acute pancreatitis.
    Clin Chim Acta. 1989 Jul 31;183(1):95-100 PMID: 2475281
Article Info
Journal
International journal of pancreatology : official journal of the International Association of Pancreatology
Abbr.
Int J Pancreatol
ISSN
0169-4197
Published
1999-06-00
Pages
195-210
Language
English
Region
United States
NLM ID
8703511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]